(This story originally appeared in 
MUMBAI: Pune-based Serum Institute, credited with affordable and innovative therapies like pneumonia and dengue monoclonal vaccines, plans to price the proposed Covid-19 vaccine at around Rs 1,000 per dose in India. Serum is one of the global manufacturers that is putting its weight behind an Oxford University-led consortium, which announced the start of human clinical trials on April 23 and is one of the first such projects to get underway globally.
“We hope to start trials in India from May, with a few hundred patients, and expect to roll out the vaccine by September–October, if the trials are successful. We are planning to make the vaccine available at an affordable price of around Rs 1,000 in India, which will take into account costs (for us)”, Serum Institute CEO and promoter Adar Poonawalla told T